s-adenosylmethionine has been researched along with Narcolepsy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Honda, M; Honda, Y; Miyagawa, T; Shigematsu, Y; Shimada, M; Tokunaga, K | 1 |
Honda, M; Honda, Y; Kawashima, M; Miyadera, H; Miyagawa, T; Shimada, M; Tanaka, S; Tokunaga, K | 1 |
Berner, J | 1 |
3 other study(ies) available for s-adenosylmethionine and Narcolepsy
Article | Year |
---|---|
Low carnitine palmitoyltransferase 1 activity is a risk factor for narcolepsy type 1 and other hypersomnia.
Topics: Carnitine; Carnitine Acyltransferases; Carnitine O-Palmitoyltransferase; Disorders of Excessive Somnolence; Fatty Acids; Humans; Narcolepsy; Risk Factors | 2022 |
Abnormally low serum acylcarnitine levels in narcolepsy patients.
Topics: Adult; Carnitine; Carnitine O-Palmitoyltransferase; Case-Control Studies; Female; Gene Expression; Genotype; Humans; Male; Middle Aged; Narcolepsy; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Sodium oxybate intolerance associated with familial serum acylcarnitine elevation.
Topics: Acyl-CoA Dehydrogenase; Carnitine; Child; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Narcolepsy; Polymorphism, Single Nucleotide; Sleep Initiation and Maintenance Disorders; Sodium Oxybate | 2013 |